The global atovaquone drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Atovaquone drug is prescribed in the treatment of pneumocytis jirovecii pneumonia. It type of pneumonia which is mostly affecting people who are infected with the human immunodeficiency virus. This drug is advised for use by adults and […]
